New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 15, 2014
09:16 EDTKO, PESI, HALO, MS, INFY, BHP, POT, ZBRA, MSI, JNJ, AANOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Coca-Cola (KO), up 2.2%... Johnson & Johnson (JNJ), up 2.1%. ALSO HIGHER: Zebra Technologies (ZBRA), up 5.5% after agreeing to acquire Motorola Solution's (MSI) enterprise unit for $3.45B. Motorola Solutions shares are up 3.5% following the news... Halozyme (HALO), up 8.5% after initiated with Buy rating at Citigroup... Potash (POT), up 2.3% after Globe & Mail says the company is speculated to be targeted again by BHP Billiton (BHP)... Morgan Stanley (MS), up 2% after upgraded at BofA Merrill Lynch. DOWN AFTER EARNINGS: Infosys (INFY), down 2.5%... Perma-fix (PESI), down 8.9%. ALSO LOWER: Aaron's (AAN), down 5% after cuttings Q1 EPS and revenue guidance, acquiring Progressive Finance Holdings for $700M, and rejecting Vintage Capital's takeover offer.
News For KO;JNJ;MSI;ZBRA;POT;BHP;INFY;MS;HALO;PESI;AAN From The Last 14 Days
Check below for free stories on KO;JNJ;MSI;ZBRA;POT;BHP;INFY;MS;HALO;PESI;AAN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 21, 2014
12:50 EDTMSDeutsche Bank divests natgas trading book to Morgan Stanley, Reuters says
Subscribe for More Information
08:31 EDTMSMorgan Stanley, JP Morgan selected by Shake Shack to lead IPO, Reuters says
JP Morgan (JPM) and Morgan Stanley (MS) have been picked by Shake Shack to lead the fast-food restaurant chain's IPO, sources tell Reuters. The offering could come as early as this year. Reference Link
08:31 EDTAANAaron's appoints Gilbert Danielson interim CEO
Subscribe for More Information
06:43 EDTMSRegulators up bank warning efforts for poor risk assessment, Reuters says
Subscribe for More Information
05:42 EDTJNJIllumina announces strategic partnership with AstraZeneca, Sanofi, Janssen
Illumina (ILMN) announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing, or NGS,-based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine. Initial strategic partners include AstraZeneca (AZN), Janssen Biotech, a Johnson & Johnson (JNJ) company, and Sanofi (SNY). Illumina is working with the strategic partners to develop assays that detect and measure multiple variants simultaneously to support partners’ clinical trials, with the objectives of securing regulatory agency approvals and test commercialization. In parallel, Illumina is working with key thought leaders to set standards for NGS-based assays in routine clinical oncology practice, as well as to define regulatory frameworks to enable this new testing paradigm. Together, Illumina and its strategic partners aim to transition from single-analyte companion diagnostics to panel-based assays that select for “companion therapeutics.”
August 20, 2014
18:29 EDTMSBofA, JPMorgan weigh plans to raise salaries for junior bankers, Bloomberg says
Subscribe for More Information
10:04 EDTBHPOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: BHP Billiton (BHP) downgraded to Underperform from Neutral at Credit Suisse... GT Advanced (GTAT) downgraded to Underperform from Outperform at CLSA... Hertz (HTZ) downgraded to Hold from Buy at Deutsche Bank... IDEXX (IDXX) downgraded to Sell from Neutral at Northcoast... Prestige Brands (PBH) downgraded to Neutral from Buy at Sidoti... Real Goods Solar (RGSE) downgraded to Neutral from Buy at Roth Capital... Regal-Beloit (RBC) downgraded to Neutral from Buy at Longbow... SunCoke Energy (SXC) downgraded to Neutral from Outperform at Credit Suisse... Tidewater (TDW) downgraded to Market Perform from Outperform at Clarkson Capital.
09:09 EDTINFYFairchild Semiconductor volatility expected to move on deal report
Subscribe for More Information
05:20 EDTBHPBHP Billiton downgraded to Underperform from Neutral at Credit Suisse
Subscribe for More Information
August 19, 2014
15:22 EDTBHPBHP Billiton downgraded to Underperform from Neutral at Credit Suisse
Subscribe for More Information
09:07 EDTBHPOn The Fly: Pre-market Movers
Subscribe for More Information
06:16 EDTBHPBHP Billiton says continues to review Nickel West, smaller assets
BHP Billiton said continues to review Nickel West, New Mexico Coal and its smaller petroleum assets. "Each of these assets is subject to its own study and the Group will only pursue options that maximise value for its shareholders," BHP stated.
06:04 EDTBHPBHP says CFO Graham Kerr to be CEO of new company
BHP Billiton announced a series of changes to the senior management of the company. Graham Kerr, currently CFO is appointed CEO designate of the new company that BHP Billiton plans to form in a demerger. Graham will retire from the Group Management Committee on October 1 and will be replaced as CFO by Peter Beaven, currently President, Copper. Brendan Harris, currently Head of Group Investor Relations, has been appointed CFO designate of the new company. BHP said an announcement relating to Beaven's replacement as President Copper will be made in due course. In the interim Edgar Basto, currently Asset President Escondida, will act in the capacity of President, Copper and, following the appointment of a permanent replacement, will take up a new role within BHP Billiton.
05:59 EDTBHPBHP Billiton to create independent metals and mining company
Subscribe for More Information
05:57 EDTBHPBHP Billiton reports FY14 underlying profit $13.45B vs. $12.21B last year
BHP said capital and exploration expenditure is expected to decline to $14.5Bin the 2015 financial year and be no more than $14B should the proposed demerger be implemented. "By maintaining an internal focus and concentrating investment in our major basins we believe an average rate of return of greater than 20% is achievable for our favoured development options," the company said. It added, "With robust volume growth and further productivity gains expected, we remain confident in the outlook for the Group. On this basis, we increased our full-year progressive base dividend by 4% to 121 US cents per share for an Underlying payout ratio of 48%. We will seek to steadily increase or at least maintain the dividend per share in US dollar terms at each half-yearly payment following the demerger, implying a higher payout ratio."
August 18, 2014
13:12 EDTKOAnalysts mixed on Monster Beverage following Coke deal
Analysts had mixed outlooks on energy drink maker Monster Beverage (MNST) in notes to investors earlier today. The analyst comments come after last Thursday night’s announcement that Monster had formed a strategic partnership with Coca-Cola, which included Coca-Cola taking a 16.7% stake in the energy drink maker. BEARISH TAKE: Jefferies analyst Kevin Grundy downgraded Monster Beverage to Hold from Buy, saying that the stock's valuation "looks full" following its rally on Friday. The potential for a strategic deal is no longer a positive catalyst for Monster's stock, as that catalyst largely played out Friday, Grundy believes. Although Coca-Cola is likely to increase its stake in Monster, it will likely take years to do so, the analyst forecast. Additionally, the growth of the global energy drink space has been slowing in recent months, creating risk for Monster, the analyst believes. However, Grundy did raise his price target on the shares to $95 from $80. BULLISH TAKE: The deal is "a big win" for both Monster and Coca-Cola, but Monster will benefit more, analysts at Wells Fargo contended. The deal should significantly increase Monster's opportunity in international markets, according to the firm. Moreover, Wells believes that the market has historically undervalued Monster's international potential, and it estimates that the company's international business is worth about $65 per share. The firm raised its price target range on the stock to $104-$106 from $79-$81 and kept an Outperform rating on the shares. Like Wells Fargo, Credit Suisse expects the deal to accelerate the growth of Monster's international business. Additionally, the firm thinks that Monster could return a significant percentage of the $2.1B it received from Coca-Cola to shareholders, either through share repurchases or a one-time dividend. Credit Suisse increased its price target on Coca-Cola to $98 from $82 and kept an Outperform rating on the shares. PRICE ACTION: In early afternoon trading, Monster dropped 4% to $89.50. On Thursday the stock closed at $71.65.
11:41 EDTJNJCubist rises after report sparks takeover interest speculation
Subscribe for More Information
07:41 EDTKOMonster Beverage price target raised to $104-$106 from $79-$81 at Wells Fargo
Subscribe for More Information
07:01 EDTBHPBHP Billiton spin off announcement doesn't create value, says Bernstein
Subscribe for More Information
06:47 EDTMSU.S. banks consider Ireland fitting spot for EU divisions, FT says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use